112 related articles for article (PubMed ID: 12571538)
1. Teriparatide (forteo) for osteoporsis.
Med Lett Drugs Ther; 2003 Feb; 45(1149):9-10. PubMed ID: 12571538
[No Abstract] [Full Text] [Related]
2. Teriparatide: new preparation. Osteoporosis: less well evaluated than alendronic acid.
Prescrire Int; 2005 Feb; 14(75):5-9. PubMed ID: 15747448
[TBL] [Abstract][Full Text] [Related]
3. Treating osteoporosis with teriparatide: many unknowns?
Shukla VK
Issues Emerg Health Technol; 2003 Nov; (51):1-4. PubMed ID: 14610756
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of osteoporosis with PTH].
Takeuchi Y
Clin Calcium; 2014 Jun; 24(6):893-902. PubMed ID: 24870841
[TBL] [Abstract][Full Text] [Related]
5. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
Gallagher JC; Rosen CJ; Chen P; Misurski DA; Marcus R
Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic agents for disorders of bone and calcium metabolism--Teriparatide, parathyroid hormone (1-34) as a daily subcutaneous injection].
Hashimoto Y; Wakayama N; Miyauchi A
Clin Calcium; 2007 Jan; 17(1):48-55. PubMed ID: 17211093
[TBL] [Abstract][Full Text] [Related]
7. [Teriparatide (human recombinant 1-34 parathyroid hormone)--a new treatment regimen for severe osteoporosis].
Vestergaard P; Nielsen LR; Mosekilde L
Ugeskr Laeger; 2004 Aug; 166(32):2653-5. PubMed ID: 15347166
[No Abstract] [Full Text] [Related]
8. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
Adachi JD; Hanley DA; Lorraine JK; Yu M
Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
[TBL] [Abstract][Full Text] [Related]
9. Teriparatide: new indication. During corticosteroid therapy: no fewer clinical fractures. Unnecessarily inconvenient.
Prescrire Int; 2009 Aug; 18(102):159. PubMed ID: 19743573
[No Abstract] [Full Text] [Related]
10. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
Brixen KT; Christensen PM; Ejersted C; Langdahl BL
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
[TBL] [Abstract][Full Text] [Related]
11. [New bone density conservation agents for osteoporosis under research and development: PTH (1-34)].
Endo I; Matsumoto T
Nihon Rinsho; 2007 Nov; 65 Suppl 9():443-6. PubMed ID: 18161146
[No Abstract] [Full Text] [Related]
12. New drug builds bone.
Harv Womens Health Watch; 2001 Jul; 8(11):2. PubMed ID: 11511464
[No Abstract] [Full Text] [Related]
13. Teriparatide (Forteo) for osteoporosis.
Bazaldua OV; Bruder J
Am Fam Physician; 2004 Apr; 69(8):1983-4. PubMed ID: 15117021
[No Abstract] [Full Text] [Related]
14. New osteoporosis strategy: boosting bone growth.
Johns Hopkins Med Lett Health After 50; 2004 Apr; 16(2):4--5. PubMed ID: 15088565
[No Abstract] [Full Text] [Related]
15. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
[TBL] [Abstract][Full Text] [Related]
16. Teriparatide: a novel agent that builds new bone.
Freeman TR
J Am Pharm Assoc (2003); 2003; 43(4):535-7. PubMed ID: 12952320
[No Abstract] [Full Text] [Related]
17. [Optimal osteoporosis strategy?].
Scharla S; Reichenhall B
Krankenpfl J; 2005; 43(1-3):65. PubMed ID: 15912853
[No Abstract] [Full Text] [Related]
18. [New medication for osteoporosis. To further increase instead of braking reduction].
MMW Fortschr Med; 2003 Oct; 145(44):44. PubMed ID: 14655508
[No Abstract] [Full Text] [Related]
19. Teriparatide for postmenopausal osteoporosis.
Drug Ther Bull; 2004 Dec; 42(12):93-5. PubMed ID: 15587764
[TBL] [Abstract][Full Text] [Related]
20. [Teriparatide--new value in osteoporosis treatment: treatment guidelines].
Korsić M; Kastelan D
Reumatizam; 2006; 53(2):77-81. PubMed ID: 17580560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
